KOSELUGO
Identification of Koselugo
| No description |
Google image searchProduct monograph
Active ingredient
selumetinib (selumetinib sulfate), 25 MG
DIN: 02530147
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: ALEXION PHARMA GMBH
Date: 02-OCT-2024
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EE — Mitogen-activated protein kinase (MEK) inhibitors (ATC, ATC/DDD)
- L01EE04 — SELUMETINIB (ATC/DDD)
Reference brand drug: Koselugo
